Imaging Technologies

Dr Jan Wolber

GE Healthcare Pharmaceutical Diagnostics

Jan Wolber is Global Product Leader Digital at GE Healthcare. He is based in Amersham in the UK. His work is focused on Artificial Intelligence solutions for image assessment and clinical decision support across multiple disease areas. The development of digital biomarkers is an integral part of the Precision Health strategy of GE Healthcare.

Jan has 20 years of experience in medical imaging R&D as a scientist, project leader and departmental manager. After studying physics at the Universities of Bayreuth in Germany and St Andrews in Scotland, Jan received his PhD from the University of London in 2000 on work in the field of hyperpolarized ¹²⁹Xe Magnetic Resonance (MR). He also has a MBA from Warwick Business School (graduation in 2014). Since 2012, Jan has held an honorary professorship in MR physics at the University of Sheffield alongside his employment at GE Healthcare. Jan has several links to Oxford University; he is chair of the External Advisory Board of the ONBI CDT and a member of the Scientific Management Committee of the SABS R³ CDT.

Jan has been involved across the innovation value chain of medical imaging from very early concepts to translational research, clinical studies and commercialisation. For instance, he was a key team member in the development and regulatory approval of GE Healthcare’s amyloid PET agent Vizamyl^TM; his team led the imaging aspects of the development studies and developed the reading methodology for this tracer. He has also been involved in the development of image analysis software.

Please contact the Translational Research Office if you would like to arrange a meeting.